Novocure News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novocure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novocure Today - Breaking & Trending Today

NovoCure Limited (NASDAQ:NVCR) Shares Purchased by C WorldWide Group Holding A S

C WorldWide Group Holding A S boosted its stake in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 135.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 521,784 shares of the medical equipment provider’s stock after acquiring an additional 300,000 shares during the period. C WorldWide […] ....

United States , Piper Sandler , Optune Gio , Optune Lua , Frankx Leonard , Worldwide Group Holding , China Universal Asset Management Co , Securities Exchange Commission , C Worldwide Group Holding , Wells Fargo Company , Associates Corp , Jpmorgan Chase Co , Financial Services Group Inc , Principal Financial Group Inc , Novocure Limited , Free Report , Universal Asset Management , Services Group , Principal Financial Group , Financial Group , Exchange Commission , Cure Limited , Get Free Report , Greater China , Visit Holdingschannel , Novocure Daily ,

NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts […] ....

United States , Optune Lua , Optune Gio , Frankx Leonard , China Universal Asset Management Co , Novocure Limited , Wells Fargo Company , Unisuper Management Pty Ltd , Us Bancorp , Jpmorgan Chase Co , Get Free Report , Super Management Pty Ltd , Universal Asset Management , Get Free , Cure Limited , Greater China , Novocure Daily , Nasdaq Nvcr ,

Wells Fargo & Company Lowers NovoCure (NASDAQ:NVCR) Price Target to $42.00

NovoCure (NASDAQ:NVCR – Get Free Report) had its target price lowered by investment analysts at Wells Fargo & Company from $49.00 to $42.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price objective indicates a potential upside […] ....

United States , Optune Gio , Optune Lua , Frankx Leonard , Jpmorgan Chase Co , China Universal Asset Management Co , Unisuper Management Pty Ltd , Us Bancorp , Securities Exchange Commission , Novocure Company Profile , Wells Fargo Company , Get Free Report , Wells Fargo , Exchange Commission , Super Management Pty Ltd , Universal Asset Management , Cure Limited , Greater China , Novocure Daily , Nasdaq Nvcr , Lower Price Target ,

Head to Head Contrast: Minerva Surgical (NASDAQ:UTRS) and NovoCure (NASDAQ:NVCR)

NovoCure (NASDAQ:NVCR – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 84.6% of NovoCure shares […] ....

Saint Helier , Jersey General , United States , Optune Lua , Santa Clara , Optune Gio , Minerva Surgical Inc , Get Free Report , Minerva Surgical , Given Minerva Surgical , Cure Limited , Greater China , Ablation System , Symphion Tissue Removal System , Resectr Tissue Resection Device , Novocure Daily , Nasdaq Nvcr , Stock Comparison , Stock Analysis ,

Novocure to Report First Quarter 2024 Financial Results

ROOT, Switzerland, April 01, 2024 Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company’s financial results for the three months ended March 31, 2024, at 8:00 a.m. EDT on Thursday, May 2, 2024. To access the conference call by phone, use the following conference call registration link and dial-in d ....

New Hampshire , United States , Exchange Commission , Investor Relations , Tumor Treating , Tumor Treating Fields , Annual Report , Private Securities Litigation Reform Act , Financial Results , Financial Markets ,